Cellworks

San Jose, United States Founded: 2005 • Age: 21 yrs
Biosimulation platform developed for therapeutic design in life sciences.
Annual revenue $2.6M Latest available
Total funding $16.5M 2 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Cellworks

Cellworks is a company based in San Jose (United States) founded in 2005. Cellworks has raised $16.52 million across 2 funding rounds. Cellworks operates in a competitive market with competitors including Genuity Science, ICarbonX, Rhelixa, Geneyx and Codetta, among others.

  • Headquarter San Jose, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.59 M (USD)
    4
    as on Mar 31, 2023
  • Net Profit
    $267.69 K (USD)
    -36
    as on Mar 31, 2023
  • EBITDA
    $430.7 K (USD)
    -24
    as on Mar 31, 2023
  • Total Equity Funding
    $16.52 M (USD)

    in 2 rounds

  • Latest Funding Round
    $13 M (USD), Series B

    Dec 26, 2012

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Cellworks

Headcount 50-200
Employee Profiles 61
Board Members and Advisors 9
Employee Profiles
People
Michele Macpherson
Chief Business Officer & CFO
People
Drew Watson
Chief Biostatistician
People
Ansu Kumar
Chief Scientific Officer
People
Ashish Jaishwal
Senior Scientist R&d

Unlock access to complete

Board Members and Advisors
people
Bill Rutter
Board Member
people
David Lawrence
Board Member
people
Richard L. Schilsky
Chairman of Advisory Board
people
Allen Lichter
Board Member

Unlock access to complete

Funding Insights of Cellworks

Cellworks has successfully raised a total of $16.52M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Cellworks

Investments
Premium access

Investment portfolio details for Cellworks

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cellworks

Premium access

Detailed financials for Cellworks

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cellworks Comparisons

Cellworks Primary company
Description
Biosimulation platform developed for therapeutic design in l...
Location
San Jose, United States
Founded Year
2005
Annual Revenue
$2.59 M (USD)
Net Profit
$267.69 K (USD)
EBITDA
$430.7 K (USD)
Employees
Not available
Premium access

Peer comparison for Cellworks

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cellworks

Cellworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genuity Science, ICarbonX, Rhelixa, Geneyx and Codetta, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-based omics data analysis solutions are provided to researchers.
Locked Locked Locked
Bioinformatics platforms are provided for health management and drug development.
Locked Locked Locked
Integrated genomic analysis platform for epigenome data is provided.
Locked Locked Locked
Provider of a clinical genetics data management platform for hospitals and genetic labs
Locked Locked Locked
Omics clinical data is analyzed through an online platform.
Premium access

Detailed competitors of Cellworks

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cellworks

Premium access

Complete news archive for Cellworks

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cellworks

Cellworks was founded in 2005 and raised its 1st funding round 4 years after it was founded.

Cellworks is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Cellworks is a funded company, having raised a total of $16.52M across 2 funding rounds to date.

Annual revenue of Cellworks is $2.59M as on Mar 31, 2023.

Founded in 2005 and based in San Jose, United States, Cellworks operates in the biotechnology sector. A biosimulation platform is provided to the life science industry, utilizing computational modeling to create frameworks for therapeutic development. Responses to FDA-approved cancer therapies are predicted, and personalized cancer therapy recommendations are offered through this platform.

Cellworks's top competitors include Watershed, Rhelixa and ICarbonX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available